OVARIAN CANCER IN PATIENTS WITH BRCA1 5382insC MUTATION

OVARIAN CANCER IN PATIENTS WITH BRCA1 5382insC MUTATION

Molecular genetic characteristics of the ovarian tumors can provide much quicker information about treatment effectiveness. The paper was aimed to study the frequency of BRCA1 5382insC mutation among ovarian cancer patients living in Siberia (the Tomsk region) and to detect the main clinical morphol...

Full description

Bibliographic Details
Main Authors:	А. B. Villert, L. А. Kolomiets, N. S. Rodicheva, А. А. Ivanova, N. V. Cherdyntseva, S. L. Stukanov
Format:	Article
Language:	Russian
Published:	Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-02-01
Series:	Sibirskij Onkologičeskij Žurnal
Subjects:	ovarian cancer brca1 5382insc mutation clinical morphological and immunohistochemical characteristics treatment efficiency
Online Access:	https://www.siboncoj.ru/jour/article/view/261

Similar Items

HEREDITARY CHARACTERISTICS BRCA1 5382INSC/СHEK2/BLM-ASSOCIATED BREAST CANCER
by: Е. М. Bit-Sava
Published: (2016-02-01)

Genotype-phenotype correlations in patients with breast cancer and BRCA1 mutations (4153delA, 185delAG, 5382insC)
by: Ye. M. Bit-Sava, et al.
Published: (2014-07-01)

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
by: Wijden Mahfoudh, et al.
Published: (2019-04-01)

Incidência das mutações 185delAG e 5382insC no gene BRCA1 em mulheres judias Ashkenazi de Porto Alegre
by: Dillenburg, Crisle Vignol
Published: (2008)

Incidência das mutações 185delAG e 5382insC no gene BRCA1 em mulheres judias Ashkenazi de Porto Alegre
by: Dillenburg, Crisle Vignol
Published: (2008)

Incidência das mutações 185delAG e 5382insC no gene BRCA1 em mulheres judias Ashkenazi de Porto Alegre
by: Dillenburg, Crisle Vignol
Published: (2008)

DETECTION OF MUTATIONS RELATED TO HEREDITARY CANCER IN RELATIVES OF BREAST CANCER PATIENTS
by: G. A. Paul, et al.
Published: (2017-09-01)

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
by: Crisle Vignol Dillenburg, et al.
Published: (2012-01-01)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
by: LILIAN JARA, et al.
Published: (2002-01-01)

Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation
by: Ibtihel Benhaj Mbarek, et al.
Published: (2017-06-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020-08-01)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
by: Tomasz Kluz, et al.
Published: (2018-02-01)

A RARE CASE OF MULTIPLE-PRIMARY CANCER IN A WOMAN WITH BRCA 1 GENE MUTATION: BRCA-ASSOCIATED OVARIAN CANCER AND LUNG CARCINOID TUMOR
by: A. О. Ivantsov, et al.
Published: (2018-03-01)

Análisis de las mutaciones más frecuentes del gen BRCA1 (185delAG y 5382insC) en mujeres con cáncer de mama en Bucaramanga, Colombia
by: María Carolina Sanabria, et al.
Published: (2009-03-01)

Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
by: Deborah Porto Cotrim, et al.
Published: (2019-01-01)

The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
by: I A Demidova
Published: (2017-01-01)

The occurrence of ovarian cancer in the population of urban and rural women, BRCA1 and BRCA2 genes mutation testing and the general rules on the patient’s consent to treatment
by: Połocka-Molińska Maria, et al.
Published: (2021-06-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

Generation of Urine Cell-Derived Non-integrative Human iPSCs and iNSCs: A Step-by-Step Optimized Protocol
by: Lin Cheng, et al.
Published: (2017-10-01)

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
by: Tingyan Shi, et al.
Published: (2018-07-01)

BRCA1 4153delA founder mutation in Russian ovarian cancer patients
by: Krylova Nadezhda, et al.
Published: (2006-09-01)

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)

High frequency of BRCA recurrent mutations in a consecutive series of unselected ovarian cancer patients
by: Chicos Andrei, et al.
Published: (2020-07-01)

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
by: Robert L. Hollis, et al.
Published: (2018-01-01)

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients
by: Christian F. Singer, et al.
Published: (2019-04-01)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
by: Lisa Krassuski, et al.
Published: (2019-08-01)

BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
by: S V Khokhlova, et al.
Published: (2016-03-01)

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
by: V.F. Esteves, et al.
Published: (2009-05-01)

Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of BRCA2 Status
by: Sayeh Saravi, et al.
Published: (2021-09-01)

Results of immunohistochemistry diagnostics of breast cancer in the region of Grodno with consideration of the BRCA1 gene mutation in triple negative cancer
by: A. Yu. Krylov, et al.
Published: (2017-08-01)

Transcriptome Patterns of <i>BRCA1</i>- and <i>BRCA2</i>- Mutated Breast and Ovarian Cancers
by: Arsen Arakelyan, et al.
Published: (2021-01-01)

BRCA 1/2-mutation related and sporadic breast and ovarian cancers: More alike than different
by: Melissa A. Burgess, et al.
Published: (2014-02-01)

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
by: Lorusso D, et al.
Published: (2018-05-01)

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer
by: Yan You, et al.
Published: (2020-03-01)

BRCA germline mutation test for all woman with ovarian cancer?
by: A. V. Paradiso, et al.
Published: (2019-06-01)

Genotype-phenotype correlations among <it>BRCA1 </it>4153delA and 5382insC mutation carriers from Latvia
by: Plakhins Grigorijs, et al.
Published: (2011-10-01)